Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1557-1571
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1557
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1557
Table 3 Assessment of randomized controlled trials
Ref. | Randomization sequence generation | Allocation concealment | Blinding of participants, personnel and outcome assessors | Incomplete outcome data | Selective reporting | Other sources of bias |
Liu et al[10], 2016 | Low risk | Low risk | High risk | Unclear risk | Unclear risk | Unclear risk |
Jiao et al[11], 2015 | Unclear risk | Unclear risk | Unclear risk | High risk | Unclear risk | Unclear risk |
Jiao et al[12], 2015 | Low risk | Low risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk |
Zheng et al[7], 2015 | Unclear risk | Unclear risk | High risk | Low risk | Low risk | Unclear risk |
Xie et al[13], 2014 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk |
Luo et al[14], 2013 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk |
Wang et al[15], 2013 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk |
Li et al[16], 2013 | Low risk | Low risk | Low risk | Unclear risk | Unclear risk | Unclear risk |
Gao et al[17], 2012 | Unclear risk | Unclear risk | High risk | Unclear risk | Unclear risk | Unclear risk |
Li et al[18], 2012 | Unclear risk | Unclear risk | Low risk | Unclear risk | Unclear risk | Unclear risk |
Yu et al[19], 2011 | Unclear risk | Unclear risk | Unclear risk | High risk | Unclear risk | Unclear risk |
- Citation: Yang X, Lan X, Zhang XL, Han ZL, Yan SM, Wang WX, Xu B, Ge WH. Intensive vs non-intensive statin pretreatment before percutaneous coronary intervention in Chinese patients: A meta-analysis of randomized controlled trials. World J Clin Cases 2022; 10(5): 1557-1571
- URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1557.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1557